21
A Follow-On Study With an H5 Influenza Vaccine for Subjects Who Participated in Study FLU-001
Condition(s):HealthyLast Updated:September 13, 2017Completed
50 Clinical Trials Sponsored by “Inovio Pharmaceuticals”, Page 3 of 5
Hide Studies Not Open or Pending
22
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Condition(s):Cervical Intraepithelial NeoplasiaLast Updated:September 7, 2018Completed
23
Fourth Dose of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + EP in Adult Females Previously Vaccinated With Three Doses of VGX-3100
Condition(s):Human Papillomavirus (HPV)Last Updated:August 10, 2018Completed
24
Study of VGX-3400X, H5N1 Avian Influenza Virus DNA Plasmid + Electroporation in Healthy Adults
Condition(s):HealthyLast Updated:September 13, 2017Completed
25
Study of PENNVAX™-B (Gag, Pol, Env) + Electroporation in HIV-1 Infected Adult Participants
Condition(s):HIV-1 Infection; HIV InfectionsLast Updated:November 9, 2012Completed
26
Phase I of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + Electroporation for CIN 2 or 3
Condition(s):Papillomavirus InfectionsLast Updated:September 13, 2017Completed
27
Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell Carcinoma
Condition(s):Head Neck CancerLast Updated:October 15, 2018Withdrawn
28
Medpulser Electroporation With Bleomycin Study to Treat Anterior Head and Neck Squamous Cell Carcinoma
Condition(s):Head and Neck CancerLast Updated:September 29, 2017Withdrawn
29
Study Using the MedPulser Electroporation System With Bleomycin to Treat Cutaneous and Subcutaneous Cancer
Condition(s):CancerLast Updated:October 3, 2017Completed
30
Study Using the Medpulser Electroporation System With Bleomycin to Treat Head and Neck Cancer
Condition(s):Head and Neck CancerLast Updated:October 3, 2017Completed